Business ❯Pharmaceutical Industry

Pricing Strategies

Market Competition Market Comparison Direct-to-Consumer Sales Market Dynamics Market Access Cost Management Discounts Market Regulation Drug Pricing Market Disparities Regulatory Environment International Trade Government Regulations Market Reactions Regulatory Compliance Market Impact Market Regulations Profit Margins Pharmacy Benefit Managers Market Availability

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Rep. Ro Khanna Files Legislation to Codify Trump’s Drug Pricing Executive Order

Trump Signs Executive Order to Slash U.S. Drug Prices by Up to 80%

Taxpayer-Funded Weight-Loss Drugs Face Scrutiny Over High Prices

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Launches Wegovy in France Without Reimbursement

Texas Sues Insulin Manufacturers and PBMs for Price Inflation

Senate Grills Novo Nordisk CEO Over High U.S. Prices for Ozempic and Wegovy

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations